Product Image

Ginkgo

Nature's Way
4.7
★ ★ ★ ★ ★
(2345 ratings)
Ginkgo
Product Image
Score70
A coherent ginkgo-gotu-kola formula with practical doses, but no meaningful standardization upgrade in the larger package.
How scoring works
Quantity:120 Capsule(s) • (60 servings)
Goals:
Brain Health
Cognitive Support
Mental Focus
Productivity Boost

Score 70

A coherent ginkgo-gotu-kola formula with practical doses, but no meaningful standardization upgrade in the larger package.
How scoring works
$30.21($0.50 per serving)
Vitacost
$ 35.49
iHerb
$ 35.49
Vitacost
$ 35.49
Amazon
$ 30.21
iHerb
$ 34.99
Report prices

Analysis

A 120 mg ginkgo extract serving gives the product a plausible circulation-based role for memory and attention. Gotu kola at 400 mg adds a second botanical aimed at traditional cognitive support.

No ginkgo marker percentages or ginkgolic-acid control appears in the supplied data. Gotu kola also lacks active-marker standardization, making batch consistency and effective strength uncertain.

The 60-serving package suits regular users who want the same focused pair in a larger format. It remains a cognitive product rather than broad vision nutrition, and its higher recurring cost is not matched by better extract documentation.

Who is it for
  • Regular users of ginkgo and gotu kola
  • Adults seeking a non-caffeine cognitive capsule
Best for
  • Ongoing cognitive-support use
  • Circulation and traditional mental-support pathways

Pros

  • Supplies 120 mg of ginkgo extract
  • Provides 400 mg of gotu kola
  • Offers 60 servings
  • Lists both actives separately

Cons

  • Ginkgo marker percentages are missing
  • No ginkgolic-acid limit is provided
  • Gotu kola lacks standardization
  • Larger format does not improve formula quality

Warnings

  • Ginkgo may raise bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Nutrient quality

75 High impact

A practical ginkgo amount and substantial gotu kola create a coherent cognitive blend. Missing ginkgo marker percentages and extract purity details limit quality assurance.

.

Ingredient transparency

75 High impact

All listed active amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

69 High impact

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

60 Moderate impact

Useful botanical amounts provide limited value at the higher serving cost. Missing standardization further weakens category competitiveness.

.
Report analysis

Goals

Brain Health
Impact
High effect
B+ Goal FitB- Strength of SupportB- CoverageA Formula Quality

Ginkgo and gotu kola form a focused cognitive blend aimed at circulation and mental resilience. The formula does not add membrane, energy, or neurotransmitter precursors beyond those botanical pathways.

Ginkgo has a full disclosed extract amount, but active-marker percentages and ginkgolic acid limits are missing. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Impact
High effect
B+ Goal FitB- Strength of SupportC+ CoverageB+ Formula Quality

Ginkgo directly targets cerebral circulation and may support memory or attention, with the clearest relevance in older adults experiencing age-related decline. Gotu kola broadens the botanical profile but has less reliable cognitive evidence.

The 120 mg ginkgo amount is appropriate, yet no active-marker standardization or ginkgolic-acid control is provided. Ginkgo may raise bleeding risk with warfarin, other anticoagulants, or antiplatelet medicines and warrants care before surgery.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Impact
High effect
C+ Goal FitB- Strength of SupportC- CoverageB+ Formula Quality

Ginkgo supplies a goal-relevant botanical amount that may support attention through cerebral circulation. Gotu kola adds a complementary traditional cognitive ingredient, though its focus evidence is less certain.

The lack of marker percentages and ginkgolic-acid controls makes extract quality difficult to confirm. Ginkgo may raise bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Productivity Boost
Impact
High effect
C+ Goal FitC Strength of SupportC CoverageA Formula Quality

Ginkgo provides a direct circulation-based route to mental clarity, with gotu kola adding supportive cognitive value. The ginkgo amount reaches a common extract range.

Missing active-marker percentages prevent confirmation that the extract matches clinically studied material. The two-botanical formula remains focused and logically constructed.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies

Ingredients

IngredientAmount per serving
Gotu kola
400 mg
Ginkgo biloba Leaf Extract
120 mg
Gluten Free Adults 18–50 Vegan Dairy Free Women Vegetarian
Report overview
Ginkgo · 120 mg OverallScore42
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The formula supplies a full clinical-range amount of ginkgo extract alongside gotu kola. Active-marker percentages and ginkgolic acid controls are not stated, so extract quality remains uncertain. The serving cost is slightly above the collection benchmark, and standardized clinical value cannot be confirmed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  2. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  3. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults.
    Kennedy DO; Scholey AB; Wesnes KA · Physiology & behavior · 2002
    Randomized trial20 participantsMental Focus forGinkgo
  4. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  5. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  6. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  7. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  12. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  13. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  14. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  15. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  16. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  17. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  18. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  19. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  20. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  21. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  22. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo